System Transmission

Top Signal

100#1 JOB

Activity

2190Ripe

+948 today

System

Livenow

Terminal Asset View

stockNASDAQ

PDSB

$0.63-3.52%

PDS Biotechnology Corporation

Overripe

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

27Overripe

Live Analysis Active

Company Mission

PDS Biotechnology Corporation develops cancer immunotherapies that help the body's own immune system recognize and attack cancer cells. Their treatments are designed for patients with various types of cancer who need alternatives to traditional chemotherapy. The company makes money through research partnerships, licensing agreements, and funding from clinical trials as they work toward getting their treatments approved for use.

PDS

Industry Context

The biotechnology industry focuses on developing medical treatments using biological systems. Companies in this space often work on treatments for serious diseases like cancer, diabetes, and rare genetic disorders.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

80Matrix

Market Momentum

36.1— Oversold / Recovery

Trend Strength

25— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

0.6x— Normal Volume

Today's Change

-3.52%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing PDSB across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 07:57 AM UTC

As-of 03-15-2026 07:41 UTC

Develops cancer treatments that train the immune system to fight tumors, earning money from research grants and future drug sales.

Technical squeeze detected as price compresses near recent lows, suggesting potential breakout when volatility expands.

Biotech sector showing interest in immunotherapy approaches, with companies developing novel treatments gaining attention from research investors, suggesting research investors.

Educational only. Not investment advice.

Precision Intelligence Model

Live Terminal Stream

Loading chart...